Archive | September, 2009
Acrux’s Promising Spray (ASX:ACR)
Australian company, Acrux has come out with a positive result from a Phase III trial after evaluating the safety and efficacy of their new testosterone spray, Axiron. The promising results of the late-stage trials of Axiron has cleared the way and now Acrux can look forward to putting an application to the Food and Drug [...]
Continue reading...First Time Home Buyers: Is Time Running Out?
30 September 2009 – 9:30 am PST
Comments Off
The stimulus tax credit of $8,000 for first time home buyers expires on November 30, 2009. That means your new house has to be signed, sealed, and delivered by the last day of November if you expect to qualify for the federal tax credit. Is it possible to buy a house, have it inspected, appraised, [...]
Continue reading...Repros’ Proellex under FDA microscope (RPRX)
30 September 2009 – 8:38 am PST
Comments Off
Repros Therapeutics Inc. (NASDAQ:RPRX)Â has received a verbal warning from the Food and Drug Administration of the United States of America about their drug Proellex. The FDA has informed Repros Therapeutics to resolve all the outstanding issues related with Proellex before they lift the clinical hold on the drug. The Food and Drug Administration panel has [...]
Continue reading...Hemispherx’s Vaccine Enhancer Making Waves in Japan (AMEX:HEB)
29 September 2009 – 4:38 am PST
Comments Off
Hemispherx Biopharma, Inc. (AMEX:HEB) is in the news after it was announced that Dr. Hasegawa the director of the Japanese National Institute of Infectious Diseases presented data on the lead compounds of Ampligen (R) (Poly I : Poly C12U) the double stranded RNA. The paper was titled “Formulations and Efficacy of the Influenza Vaccine Administered [...]
Continue reading...Introgen transformed into CMO (OTC:INGNQ)
29 September 2009 – 4:30 am PST
After filing for Chapter 11 for bankruptcy last December it looked like there was no further scope for the Austin-based Introgen Therapeutics. However, a group of Houston investors have come forward and have decided to transform the defunct pharmaceutical company into a contract manufacturing organization. Shortly after the filing of Chapter 11 by Introgen Therapeutics, [...]
Continue reading...State Mandated Foreclosure Mediation Programs Fail to Help Homeowners
29 September 2009 – 4:18 am PST
Comments Off
The National Consumer Law Center (NCLC) reviewed 25 programs in 14 states and found no evidence the programs are helping homeowners modify their mortgage loans.  The programs are self policed by the financing institutions and impose no obligations for them to act. While it may sound like a lifesaver thrown out to homeowners, in reality [...]
Continue reading...When Even Corn Becomes High-Tech DuPont (NYSE:DD)
28 September 2009 – 10:19 am PST
Comments Off
Agri-business may not seem an exciting or glamorous sector for investors to find opportunities, especially when compared to industries that come up with the whiz-bang consumer electronics and communications devices that have emerged to tempt our credit cards in the last few years. Just go to any national consumer electronics show and look at all [...]
Continue reading...Folotyn drug gets FDA approval (Nasdaq:ALTH)
28 September 2009 – 10:10 am PST
Comments Off
Allos Therapeutics Inc (Nasdaq:ALTH)Â must be delighted with joy after getting a green signal by the FDA panel for their injectable drug Folotyn, which will be used for the treatment of peripheral T-cell lymphoma, a rare kind of aggressive lymphatic cancer. The news came in early morning on 25th September, 2009 when FDA advisory panel approved [...]
Continue reading...Ambrx-Wyeth Drug Alliance (NYSE:WYE)
25 September 2009 – 1:44 pm PST
Comments Off
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) declared the formation of multi-target alliance with Ambrx Inc. in order to develop and commercialize protein drug candidates in multiple therapeutic areas which are currently undisclosed. The deal will directly help Ambrx earn payments, royalties, funds for research and milestones, but so far Ambrx has not revealed [...]
Continue reading...Avoid a Christmas Buying Blitz on Your Credit Cards
25 September 2009 – 12:10 pm PST
Comments Off
The beginning of September is the end of summer vacation and back to business. Fall is a huge retail season because of the Christmas buying blitz. And speaking of the holidays how are you planning to pay for all the festivities? Many of us have good intentions but end up maxing out our credit cards. [...]
Continue reading...
30 September 2009 – 10:30 am PST
Comments Off